ARTICLE | Company News
Hawaii Bio, Merck deal
August 16, 2010 7:00 AM UTC
Merck acquired Hawaii Biotech's Dengue fever vaccine program for an undisclosed amount. The program has been evaluated in a Phase I trial. Hawaii Biotech filed for Chapter 11 bankruptcy in December. F...